April 29, 2015 - The lead plaintiff filed a third amended complaint.

February 26, 2015 - The court granted in part and denied in part defendants' motion to dismiss.

October 23, 2014 - The defendants filed a motion to dismiss.

October 20, 2014 - The court ordered the dismissal of a single defendant without prejudice.
Augustt 20, 2015 - The court granted the defendants' motion for summary judgement and closed the case.

April 29, 2015 - A third amended complaint was filed.

September 18, 2014 - The lead plaintiff filed a second amended complaint.

September 15, 2014 - The lead plaintiff and lead counsel were appointed.

July 21, 2014 - A lead plaintiff motion was filed.

June 24, 2014 - The plaintiffs filed an amended complaint.

May 20, 2014 - An investor in shares of Biozoom Inc (OTCMKTS: BIZM previously known as Entertainment Art Inc) filed a lawsuit in the U.S. District Court for the Northern District of Ohio against KCG Americas LLC over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between May 16, 2013 and June 25, 2013.

According to the complaint the plaintiff alleges on behalf of purchasers of Biozoom Inc (OTCMKTS: BIZM) common shares between May 16, 2013 and June 25, 2013 from market maker KCG Americas LLC, that the defendants violated the Securities Exchange Act of 1934.

The plaintiff alleges that, according to an ongoing action by the Securities and Exchange Commission (“SEC”), between January 2013 and June 2013, certain Argentinean nationals opened U.S. brokerage accounts and deposited millions of shares of unregistered Entertainment Art stock into those accounts.

On March 12, 2013, Entertainment Art announced a substantial change in business operations from the development of fashionable leather bags to involvement in the biomedical industry. On April 1, 2013, Entertainment Art changed its name to Biozoom Inc and listed itself on the OTCBB.

The plaintiff claims that beginning on May 23, 2013, Biozoom Inc began issuing a series of press releases claiming it had created the world’s first portable, handheld consumer device to instantly measure certain “biomarkers,” including anti-oxidant levels, vitamin absorption, and stress levels and that after these press releases and certain stock promoters’ reiteration of their claims, Biozoom Inc’s stock price and trading volume increased significantly. The plaintiff says that between May 16, 2013 and June 19, 2013, certain Argentinean nationals sold millions of unregistered shares of Biozoom Inc for large profits, however, no registration statement was filed with the SEC in connection with the sales and the sales did not qualify for any exception from registration.

Biozoom Inc reported that its Net Loss increased to $0.14 million for the 12 months period that ended on March 31, 2013. Shares of Biozoom Inc (OTCMKTS: BIZM) dropped from $4.27 per share on June 18, 2013, to $0.16 per share on July 12, 2013.